Insta
ICMR To Conduct Study On Effectiveness Of Covishield And Covaxin In Preventing Severe Disease: Report
ICMR Logo
The Indian Council of Medical Research (ICMR) is set to study the effectiveness of the two COVID-19 vaccines currently being used in India.
The apex medical research body will start the study of the Serum Institute of India's Covishield and Bharat Biotech's indigenous Covaxin next week to examine these vaccines effectiveness against Covid-19.
Around 3,000-5,000 people in the 45 years and above age group will be examined by the ICMR as part of the study. Around 80 per cent of these people will comprise of those who have taken the Covishield shot while the rest will be those administered Covaxin.
The study will be led by the ICMR's National Institute of Epidemiology (NIE) in Chennai.
NIE's Tarun Bhatnagar was quoted in the Economic Times report as saying that the main objective of the study is to find out whether the vaccine prevents severe disease.
"We will compare people who tested negative with people who tested positive with sub-groups to look for those who were symptomatic and those hospitalised or with severe disease," Bhatnagar said.
Further, the effects of one dose of Covishield as against the two-shots administered will also be compared in the study.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
